163 related articles for article (PubMed ID: 3480768)
1. The value of CA 19-9 in gastric and colorectal carcinoma.
Safi F; Bittner R; Roscher R; Kübel R; Beger HG
Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen, CA 19-9, and CA 125 in normal and carcinomatous human colorectal tissue.
Quentmeier A; Möller P; Schwarz V; Abel U; Schlag P
Cancer; 1987 Nov; 60(9):2261-6. PubMed ID: 3481558
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
[TBL] [Abstract][Full Text] [Related]
7. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
von Kleist S
Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
[TBL] [Abstract][Full Text] [Related]
9. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies.
Heptner G; Domschke S; Domschke W
Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339
[TBL] [Abstract][Full Text] [Related]
10. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma.
Satake K; Kanazawa G; Kho I; Chung YS; Umeyama K
J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
[TBL] [Abstract][Full Text] [Related]
12. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
[No Abstract] [Full Text] [Related]
13. Tissue concentrations of CEA and CA 19-9 in the carcinogenesis of colorectal carcinoma exemplified by the adenoma-carcinoma sequence.
Fischbach W; Mössner J
Res Exp Med (Berl); 1988; 188(2):101-14. PubMed ID: 3163815
[TBL] [Abstract][Full Text] [Related]
14. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
[No Abstract] [Full Text] [Related]
16. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
[TBL] [Abstract][Full Text] [Related]
17. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
Staab HJ
Acta Gastroenterol Belg; 1987; 50(1):29-35. PubMed ID: 3480668
[No Abstract] [Full Text] [Related]
18. Serum values of CA72.4 in patients with gastrointestinal system tumors comparison with CEA and CA 19.9.
Yasasever V; Sengün Z; Saydan N; Onat H; Dalay N
Eur J Gynaecol Oncol; 1992; 13(5):403-8. PubMed ID: 1486919
[TBL] [Abstract][Full Text] [Related]
19. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
